Skip to main content
Equibles

IFP Advisors, Inc

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1641866 TAMPA, FL
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Jul 20, 2026
Position Value
$5,861
+$860 QoQ
Shares Held
402
+1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 122 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

IFP Advisors, Inc holds $55,994,797 across 217 Biotechnology names. ENTA ranks #100 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
 62,273 $15,242,562
2 TGTX
Tg Therapeutics, Inc.
 209,318 $11,499,930
3 JAZZ
Jazz Pharmaceuticals plc
 34,193 $8,239,487
4 AUPH
Aurinia Pharmaceuticals Inc.
 361,634 $6,136,928
5 VKTX
Viking Therapeutics, Inc.
 61,616 $2,403,640
6 EXEL
Exelixis, Inc.
 43,101 $2,345,125
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,968 $1,474,294
8 REGN
Regeneron Pharmaceuticals, Inc.
 1,352 $843,026

All Filings in ENTA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,861 402
2026-03-31 $5,001 396
2025-12-31 $6,244 396
2025-09-30 $4,740 396
2025-06-30 $2,910 385
2024-12-31 $17 3
2021-06-30 $0 0
2021-03-31 $0 0
2020-12-31 $0 0
2020-09-30 $11,857 259
2020-06-30 $0 0
2020-03-31 $0 0